These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 12576821)

  • 21. Prognostic factors of outcome after radical cystectomy for bladder cancer: a retrospective study of a homogeneous patient cohort.
    Bassi P; Ferrante GD; Piazza N; Spinadin R; Carando R; Pappagallo G; Pagano F
    J Urol; 1999 May; 161(5):1494-7. PubMed ID: 10210380
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effectiveness of adjuvant chemotherapy in transitional cell carcinoma of the urinary bladder with lymph node involvement and/or lymphovascular invasion treated by radical cystectomy.
    Park J; Park S; Song C; Doo C; Cho YM; Ahn H; Kim CS
    Urology; 2007 Aug; 70(2):257-62. PubMed ID: 17826485
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The association between extent of lymphadenectomy and survival among patients with lymph node metastases undergoing radical cystectomy.
    Wright JL; Lin DW; Porter MP
    Cancer; 2008 Jun; 112(11):2401-8. PubMed ID: 18383515
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nodal involvement in bladder cancer cases treated with radical cystectomy: incidence and prognosis.
    Abdel-Latif M; Abol-Enein H; El-Baz M; Ghoneim MA
    J Urol; 2004 Jul; 172(1):85-9. PubMed ID: 15201743
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic significance of lymphatic, vascular and perineural invasion for bladder cancer patients treated by radical cystectomy.
    Muppa P; Gupta S; Frank I; Boorjian SA; Karnes RJ; Thompson RH; Thapa P; Tarrell RF; Herrera Hernandez LP; Jimenez RE; Cheville JC
    Pathology; 2017 Apr; 49(3):259-266. PubMed ID: 28259358
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical outcomes following radical cystectomy for primary nontransitional cell carcinoma of the bladder compared to transitional cell carcinoma of the bladder.
    Rogers CG; Palapattu GS; Shariat SF; Karakiewicz PI; Bastian PJ; Lotan Y; Gupta A; Vazina A; Gilad A; Sagalowsky AI; Lerner SP; Schoenberg MP
    J Urol; 2006 Jun; 175(6):2048-53; discussion 2053. PubMed ID: 16697800
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Histologic tumor growth pattern is significantly associated with disease-related survival in muscle-invasive transitional cell carcinoma of the urinary bladder.
    Krüger S; Noack F; Böhle A; Feller AC
    Oncol Rep; 2004 Sep; 12(3):609-13. PubMed ID: 15289845
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transitional cell carcinoma involving the prostate with a proposed staging classification for stromal invasion.
    Esrig D; Freeman JA; Elmajian DA; Stein JP; Chen SC; Groshen S; Simoneau A; Skinner EC; Lieskovsky G; Boyd SD; Cote RJ; Skinner DG
    J Urol; 1996 Sep; 156(3):1071-6. PubMed ID: 8709310
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary invasive versus progressive invasive transitional cell bladder cancer: multicentric study of overall survival rate.
    Ferreira U; Matheus WE; Nardi Pedro R; Levi D'Ancona CA; Reis LO; Stopiglia RM; Denardi F; Rodrigues Netto N; de Cássio Zequi S; da Fonseca FP; Lopes A; Cardoso Guimarães G; de Carvalho Fernandes R; Cardenuto Perez MD
    Urol Int; 2007; 79(3):200-3. PubMed ID: 17940350
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic factors in stage T1 bladder cancer: tumor pattern (solid or papillary) and vascular invasion more important than depth of invasion.
    Andius P; Johansson SL; Holmäng S
    Urology; 2007 Oct; 70(4):758-62. PubMed ID: 17991551
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of lymph node density in predicting survival of patients with lymph node metastases after radical cystectomy: a multi-institutional study.
    Osawa T; Abe T; Shinohara N; Harabayashi T; Sazawa A; Kubota K; Matsuno Y; Shibata T; Shinno Y; Kamota S; Minami K; Sakashita S; Kumagai A; Mori T; Nonomura K
    Int J Urol; 2009 Mar; 16(3):274-8; discussion 278. PubMed ID: 19087211
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Radical cystectomy in the treatment of cancer of the bladder].
    Herranz Amo F; Díez Cordero JM; Verdú Tartajo F; Bielsa Carrillo A; García Burgos J; Subirá Ríos D; Castaño González I
    Arch Esp Urol; 2000 Sep; 53(7):619-24. PubMed ID: 11037655
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The significance of lymphovascular invasion in transurethral resection of bladder tumour and cystectomy specimens on the survival of patients with urothelial bladder cancer.
    Streeper NM; Simons CM; Konety BR; Muirhead DM; Williams RD; O'Donnell MA; Joudi FN
    BJU Int; 2009 Feb; 103(4):475-9. PubMed ID: 18990174
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A clinicopathological study of 218 patients with bladder carcinoma treated by radical cystectomy].
    Mitsuhata N; Takenaka T; Uesugi T; Mannami R; Mannami M; Shishido S; Masuda H; Nakano Y
    Gan To Kagaku Ryoho; 1997 Dec; 24(15):2239-44. PubMed ID: 9422068
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of American Joint Committee on Cancer pathologic stage T3a versus T3b urothelial carcinoma: analysis of patient outcomes.
    Boudreaux KJ; Chang SS; Lowrance WT; Rumohr JA; Barocas DA; Cookson MS; Smith JA; Clark PE
    Cancer; 2009 Feb; 115(4):770-5. PubMed ID: 19152431
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical study on recurrence in bladder cancer patients undergoing total cystectomy--statistical analysis of factors related to recurrence.
    Honda N; Yamada Y; Mitsui K; Mizumoto H; Taki T; Kamijyo A; Okada M; Hibi H; Fukatsu H
    Hinyokika Kiyo; 1999 May; 45(5):317-24. PubMed ID: 10410313
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [New markers for pharmacological targeting in bladder cancer with lymph node metastasis].
    Herrmann E; Eltze E; Köpke T; Bolenz C; Bierer S; Neumann J; Hertle L; Wülfing C
    Aktuelle Urol; 2007 Sep; 38(5):392-7. PubMed ID: 17907066
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic significance of hydronephrosis in bladder cancer treated by radical cystectomy.
    Resorlu B; Baltaci S; Resorlu M; Ergun G; Abdulmajeed M; Haliloglu AH; Gogus C; Beduk Y
    Urol Int; 2009; 83(3):285-8. PubMed ID: 19829026
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Macroscopic, but not microscopic, perivesical fat invasion at radical cystectomy is an adverse predictor of recurrence and survival.
    Bastian PJ; Hutterer GC; Shariat SF; Rogers CG; Palapattu GS; Lotan Y; Vazina A; Amiel GE; Gupta A; Sagalowsky AI; Lerner SP; Schoenberg MP; Karakiewicz PI;
    BJU Int; 2008 Feb; 101(4):450-4. PubMed ID: 17850359
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Prognostic value of lymphatic metastasis in bladder cancer].
    Martínez-Piñeiro L; Madrid J; Julve E; García Cardoso JV; Ortega L; de la Peña J; Martínez-Piñeiro JA
    Arch Esp Urol; 1997 May; 50(4):365-71. PubMed ID: 9313045
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.